Posted on 8/31/20
In the Race for a Coronavirus Vaccine, Can There Be Multiple Winners?
Everyone is wondering which company will win the race to produce a coronavirus vaccine. With 31 candidates in clinical development and six of those in phase . . .
Posted on 8/31/20
Has The COVID-19 Vaccine Stock Bubble Burst?
COVID-19 vaccine stocks have easily been the hottest niche across the entire market since March. Developmental-stage companies like Inovio Pharmaceuticals (NASDAQ:INO), Moderna (NASDAQ:MRNA), Novavax (NASDAQ:NVAX), Vaxart . . .
Posted on 8/31/20
How Moderna Will Fare After Posting Strong Clinical Results
SummaryModerna posted strong clinical results that failed to lift shares.Phase 3 results will follow over the next two years.Analysts have a bullish price target.Looking for more . . .
Posted on 8/31/20
Moderna in Talks to Sell 40 Million Coronavirus Vaccine Doses to Japan
Moderna (NASDAQ:MRNA) is in talks with Japan's Ministry of Health, Labour and Welfare to sell 40 million doses of its coronavirus vaccine mRNA-1273. If the sides . . .
Posted on 8/31/20
3 Red Flags for Moderna's Potential Coronavirus Vaccine
Moderna's (NASDAQ:MRNA) coronavirus vaccine efforts have made the biotech into a household name, fueling its impressive stock-price growth in the process. As shown by positive data . . .
Posted on 8/31/20
Parexel and Pfizer Enter Next Phase of Decade-Long Partnership
BOSTON and DURHAM, N.C., Aug. 27, 2020 (GLOBE NEWSWIRE) -- Parexel, a leading provider of solutions to accelerate the development and delivery of innovative new therapies . . .
Posted on 8/28/20
Entasis Therapeutics Announces $25 Million Private Placement
WALTHAM, Mass., Aug. 28, 2020 (GLOBE NEWSWIRE) -- Entasis Therapeutics Holdings Inc. (Nasdaq: ETTX) (“Entasis”), a clinical-stage biopharmaceutical company focused on the discovery and development of . . .
Posted on 8/27/20
Natera Announces Collaboration with Massachusetts General Hospital
Natera, Inc. (NASDAQ: NTRA), a pioneer and global leader in cell-free DNA, today announced a collaborative agreement with Mass General Cancer Center (MGCC) of Massachusetts General . . .
Posted on 8/27/20
Relay Therapeutics Reports Second Quarter 2020 Financial Results
CAMBRIDGE, Mass., Aug. 27, 2020 (GLOBE NEWSWIRE) -- Relay Therapeutics, Inc. (Nasdaq: RLAY), a clinical-stage precision medicine company transforming the drug discovery process by leveraging unparalleled . . .
Posted on 8/27/20
Moderna Reports Positive Results for Coronavirus Vaccine Candidate in Elderly Patients
Moderna (NASDAQ:MRNA) was again in the headlines on Wednesday, following hopeful news about its mRNA-1273 coronavirus vaccine candidate.The company revealed that in a small, early-stage clinical . . .
Posted on 8/27/20
Why Moderna Stock Zoomed Higher on Wednesday
What happenedModerna (NASDAQ:MRNA) closed nearly 6.5% higher on Wednesday thanks to the results of an early-stage clinical study of its coronavirus candidate on older patients.In the . . .
Posted on 8/26/20
Radius Health Provides Business Update
WALTHAM, Mass., Aug. 25, 2020 (GLOBE NEWSWIRE) -- Radius Health, Inc. (Nasdaq: RDUS) today announced a business update including the extension of the patent for TYMLOS® as . . .
Posted on 8/26/20
Yield10 Bioscience Closes $4M Public Offering
WOBURN, Mass., Aug. 26, 2020 (GLOBE NEWSWIRE) -- Yield10 Bioscience, Inc. (Nasdaq: YTEN), an agricultural bioscience company, today announced the closing of its previously announced underwritten . . .
Posted on 8/26/20
CVS Health Corporation Announces Pricing of Tender Offers
CVS Health Corporation(NYSE: CVS) announced today the applicable Reference Yields and Total Consideration (each as summarized in the tables below) to be paid in connection with . . .
Posted on 8/26/20
Myomo Extends and Strengthens its Global MyoPro Patent Portfolio
CAMBRIDGE, Mass.--(BUSINESS WIRE)--Myomo, Inc. (NYSE American: MYO), a wearable medical robotics company that offers increased functionality for those suffering from neurological disorders and upper-limb paralysis, today . . .
Posted on 8/26/20
ForwardVue Pharma Secures Funding
ForwardVue Pharma has secured initial seed round funding in order to advance pre-clinical development of potent long acting anti-angiogenic molecules directed against diabetic eye
Posted on 8/26/20
ImmunoGen: Turning Around In A Coronavirus Environment
SummaryImmunoGen is a turnaround stock that has tremendous potential. After temporary regulatory and clinical setbacks, the company is on a vigorous campaign for a change.Using precision . . .
Posted on 8/25/20
Kymera Therapeutics Closes IPO
WATERTOWN, Mass., Aug. 25, 2020 (GLOBE NEWSWIRE) -- Kymera Therapeutics, Inc. (NASDAQ: KYMR), a biopharmaceutical company focused on discovering and developing novel small molecule therapeutics that . . .
Posted on 8/25/20
Sonde Health Acquires NeuroLex Labs
BOSTON--(BUSINESS WIRE)--Sonde Health, a leading vocal biomarker technology platform that detects health symptoms from a few seconds of voice, today announced it has acquired NeuroLex Laboratories, . . .
Posted on 8/24/20
EyePoint Pharmaceuticals Secures New Purchase and Marketing Agreement with Vantage Outsourcing for DEXYCU
WATERTOWN, Mass., Aug. 24, 2020 (GLOBE NEWSWIRE) -- EyePoint Pharmaceuticals, Inc. (NASDAQ: EYPT), a pharmaceutical company committed to developing and commercializing innovative ophthalmic products, today announced . . .
Posted on 8/24/20
Harbour BioMed Signs Strategic Collaboration Agreement with Vir Biotechnology
Harbour BioMed (HBM), a global clinical-stage biopharmaceutical company today announced that it has entered into a strategic collaboration with Vir Biotechnology (Nasdaq: VIR), a clinical-stage immunology . . .
Posted on 8/24/20
Yumanity Therapeutics and Proteostasis Therapeutics Merge
Yumanity Therapeutics and Proteostasis Therapeutics, Inc. (Nasdaq: PTI) today announced that the companies have entered into a definitive merger agreement.
Posted on 8/24/20
Biogen: There Are Risks, But There Is Value Too
SummaryBiogen has had a fluctuating share price, primarily tied to aducanumab.The firm is profitable, and has a strong balance sheet, but the stock is not without . . .
Posted on 8/24/20
Forget Moderna: Novavax Is the Coronavirus Vaccine Stock You'll Really Want to Watch
Moderna (NASDAQ:MRNA) ranks as one of the most talked-about biotechs around. Its rapid progress in developing a coronavirus vaccine candidate catapulted the company into the national . . .
Posted on 8/24/20
Is Warren Buffett Giving Up On Bank Stocks?
We recently got our quarterly glimpse at what Berkshire Hathaway's (NYSE:BRK.A) (NYSE:BRK.B) stock portfolio looks like, and to say that there were some big surprises would . . .
Boston
